文献速递艾滋病与性传播感染

围产期HIV感染青年长期抑制性ART下完整与缺陷前病毒动态

Dynamics of Intact and Defective Human Immunodeficiency Virus Type 1 (HIV-1) Proviruses During Decades of Suppressive Antiretroviral Treatment in Young Adults With Perinatal HIV.
PubMed 文献 · J Infect Dis · 2026-01-01

该研究在围产期HIV感染青年中比较早期(<1岁)与晚期(1–5岁)实现病毒抑制者接受长达20年抑制性ART后完整与缺陷HIV前病毒的动态。早期抑制者完整HIV储存库显著更低,67%样本低于检测限,且女性晚期抑制者完整储存库更大、缺陷前病毒随时间增加更明显。

要点

  • 围产期HIV感染中1岁内实现病毒抑制者5年时完整前病毒载量显著更低,且维持至青年期。
  • 晚期抑制者中女性完整储存库大于男性,缺陷前病毒随时间增加更明显。
  • 提示需按抑制时机与性别制定个体化无ART缓解与治愈策略。

核心结论

  • 围产期HIV感染在1岁内实现病毒抑制可使5岁时完整HIV储存库显著更小,并维持至青年期。
  • 晚期抑制者中女性完整储存库更大且缺陷前病毒随时间增加更多,提示性别差异影响HIV持续。

研究设计与样本

  • 基于PHACS青少年主方案的201份外周血单核细胞样本研究,参与者年龄17.6–21.2岁。
  • 共评估26名参与者(早期抑制11例、晚期抑制15例),病毒抑制维持最长20年。

主要发现

  • 早期抑制者67%样本完整HIV低于检测限(2.0拷贝/10^6 PBMCs)。
  • 病毒抑制5年时早期抑制者平均完整前病毒载量2.0 vs 晚期抑制者6.6拷贝/10^6 PBMCs。
  • 晚期抑制者中女性平均完整储存库12.5 vs 男性4.1拷贝/10^6 PBMCs,且缺陷前病毒随时间增加更明显。

临床怎么用

  • 围产期HIV感染应尽早实现病毒抑制以减小完整储存库,为无ART缓解策略提供依据。
  • 治愈研究需考虑性别差异,女性晚期抑制者可能需更强化干预。

局限性

  • 样本量较小(26名参与者),结论需更大队列验证。
  • 仅分析外周血单核细胞,未涉及组织储存库。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Understanding HIV-1 reservoir dynamics during long-term antiretroviral therapy (ART) in youth with perinatal Human Immunodeficiency Virus Type-1 (HIV-1) is essential for ART-free remission strategies. METHODS: We quantified intact and defective HIV proviruses in 201 peripheral blood mononuclear cell samples (PBMCs) from participants ages 17.6-21.2 years in the Pediatric HIV/AIDS Cohort Study (PHACS) Adolescent Master Protocol. Participants were classified as early-suppressed (ES, <1 year of age at virologic suppression [VS]) or late-suppressed (LS, 1-5 years of age at VS) and had maintained VS for up to 20 years. RESULTS: Twenty-six participants (11 ES and 15 LS) were evaluated. Early-suppressed participants exhibited significantly lower intact HIV reservoirs compared with LS participants, with 67% of ES samples below detection limits (2.0 copies/106 PBMCs). By 5 years of VS, the ES participants had significantly lower mean intact proviral load (2.0 vs 6.6 copies/106 PBMCs) than LS participants, largely driven by faster clearance of intact proviruses in the first 5 years of VS. Among LS participants, females had larger intact reservoirs than males (mean: 12.5 vs 4.1 intact copies/106 PBMCs) and exhibited greater increases in defective proviruses over time. CONCLUSIONS: Achieving VS by 1 year of age in perinatal HIV infection results in substantially smaller HIV intact reservoirs by age 5, with effects sustained through young adulthood. Additionally, sex-based differences, larger intact reservoirs and increases in defective proviruses in females, underscore the need for tailored ART-free remission and cure strategies for this population. This study looked at how the amount of intact HIV, also known as the HIV reservoir, changes over time in young people with perinatal HIV who have been taking antiretroviral treatment for many years. When a person first acquires HIV, the virus forms a reservoir in long-lived CD4+ memory T cells, which allows HIV to rebound if antiretroviral treatment is stopped. We analyzed blood samples from 26 young adults who were enrolled in a long-term study of pediatric HIV. We compared the size of the HIV reservoir in individuals who suppressed their HIV from early infancy with those who achieved viral suppression in later childhood. We found that after 5 years, young adults who started treatment early in life had much smaller amounts of intact HIV than those treated later. Among the participants who achieved viral suppression later, we also observed differences between males and females: Females had larger HIV reservoirs. Overall, our findings show that starting HIV treatment in early life can significantly reduce the size of the HIV reservoir and highlight important sex-based differences in HIV persistence. These insights point to the need for personalized approaches in future efforts to achieve an HIV cure.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Khetan P, Patel K, Yu W, et al. Dynamics of Intact and Defective Human Immunodeficiency Virus Type 1 (HIV-1) Proviruses During Decades of Suppressive Antiretroviral Treatment in Young Adults With Perinatal HIV. J Infect Dis. 2026. PMID: 41616083. doi:10.1093/infdis/jiag045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。